← Scoopfeeds — Intelligent news, curated.
Cantor Fitzgerald Reiterates Overweight Rating on Gilead Sciences (GILD) Following Positive HIV Trial Results
business

Cantor Fitzgerald Reiterates Overweight Rating on Gilead Sciences (GILD) Following Positive HIV Trial Results

Yahoo Finance · Jun 26, 2026, 11:11 AM · Also reported by 3 other sources

Cantor Fitzgerald Reiterates Overweight Rating on Gilead Sciences (GILD) Following Positive HIV Trial Results

Read full story on Yahoo Finance → More top stories

Also covered by

Investing.com Cantor Fitzgerald reiterates CrowdStrike stock rating on strong results Investing.com Cantor Fitzgerald reiterates ON Semiconductor stock rating on acquisition Investing.com Cantor Fitzgerald reiterates JFrog stock rating on cloud growth

More in business

Yahoo Finance
Is This the Best Tech ETF to Buy With $1,000 Right Now?
Yahoo Finance
Inflation flips Wall Street's Fed interest-rate bets
Investing.com
UBS outlines portfolio playbook for uncertain markets
Bloomberg Markets
Pointed News Quiz | Reddit, Music, YA Novels
Yahoo Finance
Fast-food chain closes 70 restaurants, even bigger cuts coming
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop